Benitec Biopharma Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Benitec Biopharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2024.
  • Benitec Biopharma Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.79M, a 1.41% increase year-over-year.
  • Benitec Biopharma Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$22.4M, a 9.97% decline year-over-year.
  • Benitec Biopharma Inc. annual Operating Income (Loss) for 2024 was -$22.5M, a 17.9% decline from 2023.
  • Benitec Biopharma Inc. annual Operating Income (Loss) for 2023 was -$19.1M, a 6.87% decline from 2022.
  • Benitec Biopharma Inc. annual Operating Income (Loss) for 2022 was -$17.9M, a 31.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$22.4M -$5.79M +$83K +1.41% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$22.5M -$5.55M -$998K -21.9% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-26
Q1 2024 -$21.5M -$4.14M +$200K +4.61% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$21.7M -$6.93M -$1.32M -23.5% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$20.4M -$5.87M -$1.29M -28.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$19.1M -$4.55M +$187K +3.95% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-26
Q1 2023 -$19.3M -$4.34M -$881K -25.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$18.4M -$5.61M -$775K -16% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$17.6M -$4.58M +$242K +5.02% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$17.9M -$4.74M -$883K -22.9% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-21
Q1 2022 -$17M -$3.46M +$333K +8.78% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$17.3M -$4.84M -$1.58M -48.4% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 -$15.7M -$4.82M -$2.13M -79.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$13.6M -$3.85M -$961K -33.2% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-02
Q1 2021 -$12.6M -$3.79M -$1.68M -79.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$11M -$3.26M -$1.15M -54.4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$9.81M -$2.69M -$1.52M -131% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$8.28M -$2.89M Apr 1, 2020 Jun 30, 2020 10-K 2021-09-20
Q1 2020 -$2.11M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$2.11M Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 -$1.17M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.